Development of controlled release sildenafil formulations for vaginal administration

Drug Delivery

Volumn 15, Issue 4, 2008, Pages 259-265

  Deǧim, I Tuncer ^a   Tuǧcu Demiröz, Fatmanur ^a   Tamer Ilbasmis, Sibel ^a   Acartürk, Füsun ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Infertility; Sildenafil; Vaginal Insert; Vaginal Suppository; Vaginal Tablet

Indexed keywords

EUDRAGIT RS; POLYMER; SILDENAFIL; WITEPSOL H 15;

ARTICLE; CONTROLLED RELEASE FORMULATION; DRUG FORMULATION; PRIORITY JOURNAL; SUPPOSITORY;

ACRYLIC RESINS; ADMINISTRATION, INTRAVAGINAL; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; FEMALE; HUMANS; INFERTILITY, FEMALE; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; POLYVINYLS; PURINES; SULFONES; SUPPOSITORIES; TABLETS; TRIGLYCERIDES;

EID: 43049147681     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540802006781     Document Type: Article

References (49)

1. Acartürk, F., Deǧim, T., Tuǧcu-Demiröz, F., and İbasmi, S. 2003. Vaginal controlled release sildenafil tablets, First EUFEPS conference on Optimising drug delivery and formulation: New challenges in drug delivery APGI, Paris, France.
2. Ahuja, A., Khar, R. K., and Ali, J. 1997. Mucoadhesive drug delivery systems, Drug Dev. Ind. Pharm. 23:489-515.
3. Andersson, K. E., and Stief, C. 2000. Penile erection and cardiac risk: Pathophysiologic and pharmacologic mechanisms. Am. J. Cardiol. 86:Suppl, 23F-26F.
4. Artursson, P., Lindmark, T., Davis, S. S., and lllum, L. 1994. Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (CAC O-2). Pharm. Res. 11:1358-1361.
5. Ballard, S. A., Gingell, C. J., Tang, K., Turner, L. A., Price, M. E., and Naylor, A. M. 1998. Effects of Sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isoenzymes. J. Urol. 159:2164-2171.
6. Bernkop-Schnurch, A., Hornof, M., and Zoidl, T. 2003. Thiolated polymers - Thiomers: Modification of chitosan with 2-iminothiolane. Int. J. Pharm. 260:229-237.
7. Boskey, E. R., Cone RA Whaley, K. J., and Moench, D. R. 2001. Origins of vaginal acidity: high D/L lactate ratio is consistent with bacteria being the primary source. Hum. Reprod. 16:1809-1813.
8. Boyce, E. G., and Umland, E. M. 2001. Sildenafil citrate: A therapeutic update. Clini. Therapeutics. 23: 2-23.
9. Brannon-Peppas, L. 1993. Novel vaginal drug release applications. Adv. Drug Deliv. Rev. 11:169-177.
10. Carson, D. D., Bagchi, I., Dey, S. K., Enders, A. C., Fazleabas, A. T., Lessey, B. A., Bruce, A., Yoshinaga, L., and Yoshinaga, K. 2000. Embryo implantation. Dev. Biol. 223: 217-237.
11. Ceschel, G. C., Maffei, P., Lombardi, B. S., Ronchi, C., and Rossi, S. 2001. Development of a mucoadhesive dosage form for vaginal administration. Drug Dev. Ind. Pharm. 27:541-554.
12. Degim, Z., Degim, T., Acarturk, F., Erdogan, D., Ozogul, C., and Koksal, M. 2005. Rectal and vaginal administration of insulin-chitosan formulations: an experimental study in rabbits. J. Drug Target. 3:563-572.
13. Dodane, V., and Vilivalam, V. D. 1998. Pharmaceutical applications of chitosan, Pharm. Sci. Technol. Today, 1:246-253.
14. Duchene, D., and Ponchel, G. 1992. Principle and investigation of the bioadhesion mechanism of solid dosage forms. Biomaterials 13:709-714.
15. Edi-Osagie, E. C. O., Seif, M. W., Aplin, J. D., Jones, C. J. P., Wilson, G., Path, M. R. C., and Lieberman, B. A. 2004. Characterizing the endometrium in unexplained and tubal factor infertility: a multiparametric investigation. Fertil. Steril. 82: 1379-1389.
16. El-Kamel, A. H., Sokar, M. S., Naggar, V. F., and Al-Gamal, S. 2004. Chitosan and sodium alginate-based bioadhesive vaginal tablets. AAPS Pharm Sci. 4:E44.
17. Felt, O., Buri, P., and Gurny, R. T. 1998. Chitosan: a unique polysaccharide for drug delivery. Drug Dev. Ind. Pharm. 24:979-1003.
18. Ferrer, J. 2000. Vaginal candidosis: epidemiological and etiological factors. Int. J. Gynaecol. Obstet. 71:S21-S27.
19. Fiorilli, A., Molteni, B., and Milani, M. 2005. Successful treatment of bacterial vaginosis with a polycarbophil-carbopol acidic vaginal gel: results from a randomised double-blind, placebo-controlled trial. Eur. J. Obstet. Gynecol. Reprod. Biol. 120:202-205.
20. Genc, L., Oguzlar, C., and Guler, E. 2000. Studies on vaginal bioadhesive tablets of acyclovir. Pharmazie 55:297-299.
21. Graham, R. A., Seif, M. W., Aplin, J. D., Li, T. C., Cooke, I. D., and Rogers, A. W. 1990. An endometrial factor in unexplained infertility, BMJ 300:1428-1431.
22. Illum, L. 1998. Chitosan and its use as a pharmaceutical excipient. Pharm. Res. 15:1326-1331.
23. Issa, M. M., Koping-Hoggard, M., and Artursson, P. 2005. Chitosan and the mucosal delivery of biotechnology drugs". Drug Discov. Today 2:1-6.
24. Kim, K. W., Thomas, R. L., Lee, C., and Park, H. J. 2003. Antimicrobial activity of native chitosan, degraded chitosan, and Ocarboxymethylated chitosan. J. Food Prot. 66:1495-1498.
25. Klentzeris, L. D., Bulmer, J. N., Li, T. C., Morrison, L., Warren, A., and Cooke, I. D. 1991. Lectin binding of endometrium in women with unexplained infertility. Fertil. Steril. 56:660-667.
26. Khanvilkar, K., Donovan, M. D., and Flanagan, D. R. 2001. Drug transfer through mucus. Adv. Drug Deliv. Rev. 48:173-193.
27. Kloner, R. A., and Zusman, R. M. 1999. Cardiovascular effects of sildenafil citrate and recommendations for Its use. Am. J. Cardiol. 84:11N-17N.
28. Lanchares, J. L., and Hernandez, M. L. 2000. Recurrent vaginal candidiasis changes in etiopathogenical patterns, Int. J. Gynaecol. Obstet., 71:S29-S35.
29. Lehr, C. M., Bouwstra, J. A., Schacht, E. H., and Junginger, H. E. 1992. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int. J. Pharm. 78:43-48.
30. Lessey, B. A., Castlebaum, A. J., Swain, S. W., and Sun, J. 1995. Integrins as markers of uterine receptivity in women with primary unexplained infertility. Fertil. Steril. 63:535- 542.
31. Liaw, J., and Chang, T. W. 2001. Determination of transdermal sildenafil in nude mouse skin by reversed- phase high- performance liquid chromatography. J. Chromatog. B. 765:161-166.
32. Luessen, H. L., Leeuw, B. J., Langemeyer, M. W., Boer, A. B., Verhoef, J. C., and Junginger, H. E. 1996. Mucoadhesive polymers in peroral peptide drug delivery: VI. Carbomer and chitosan improve the intestinal absorption of the peptide drug buserelin in vivo. Pharm. Res. 13:1668-1672.
33. Martina, L., Wilsona, C. G., Kooshab, F., and Uchegbua, I. F. 2003. Sustained buccal delivery of the hydrophobic drug denbufylline using physically cross-linked palmitoyl glycol chitosan hydrogels. Eur. J. Pharm. Biopharm. 55:35-45.
34. Miyazaki, S., Nakayama, A., Oda, M., and Takad, M. 1994. Chitosan and sodium alginate based bioadhesive tablets for intra oral drug delivery. Biol. Pharm. Bull. 17:745-747.
35. Nevado, J. J. B., Flores, J. R., Peńalvo, G. C., and Farińas, N. G. 2002. Determination of sildenafil citrate and its main metabolite by sample stacking with polarity switching using micellar electrokinetic chromatography. J. Chromatog. A. 953:279-286.
36. Neves, J., and Bahia, M. F. 2006. Gels as vaginal drug delivery systems. Int. J. Pharm. 318:1-14.
37. Nigalaye, A. G., Adusumilli, P., and Bolton, S. 1990. Investigation of prolonged drug release from matrix formulations of chitosan. Drug Dev. Ind. Pharm. 16:449-467.
38. Peppas, N. A., and Bury, P. A. 1985. Surface interfacial and molecular aspects of polymer bioadhesion on soft tissues. J. Control. Release 2:257-275.
39. Robinson, J. R., and Mlynek, G. M. 1995. Bioadhesive and phase-change polymers for ocular drug delivery. Adv. Drug Deliv. Rev. 16:45-50.
40. Sawayanagi, Y., Nambu, N., and Nagai, T. 1982. Use of chitosan for sustained release preparations of water soluble drugs. Chem. Pharm. Bull. 31:4213-4215.
41. Schwartz, L. B., Chiu, A. S., Courtney, M., Krey, L., and Schmidt-Sarosi, C. 1997. The embryo versus endometrium controversy revisited as it relates to predicting pregnancy outcome in in-vitro fertilization-embryo transfer cycles, Hum. Reprod. 12:45-50.
42. Sher, G., and Fisch, J. D. 2002. Effect of vaginal sildenafil on the outcome of in vitro fertilization (IVF) after multiple IVF failures attributed to poor endometrial development. Fertil. Steril. 78:1073-1076.
43. Stewart-Tull, D. E. S. 1964. Evidence that vaginal lactobacilli do not ferment glycogen. J. Obstet. Gynaecol. 88:676-679.
44. Telfer, J. F., Irvine, G. A., Kohnen, G., Cambell, S., Cameron, S., and Cameron, I. T. 1997. Expresion of endothelial and inducible nitric oxide synthase in non-pregnant and decidualized human endometrium. Mol. Hum. Reprod. 3:69-75.
45. Thacharodi, D., and Panduranga, R. K. 1996. Collagen-chitosan composite membranes controlled transdermal delivery of nifedipine and propranolol hydrochloride. Int. J. Pharm. 134:239-241.
46. Valenta, C. 2005. The use of mucoadhesive polymers in vaginal delivery. Advanced Drug Delivery Reviews. 57:1692-1712.
47. Vermani, K., and Garg, S. 2000. The scope and potential of vaginal drug delivery. Pharm. Sci. Technol. Today 3:359-364.
48. Walsh, P. 2001. Physicians' Desk Reference, 55th Edition, Medical Economics Company, Montvale.
49. Wyshak, G. 2001. Infertility in American college alumnae. Int. J. Gynecol. Obstet. 73:237-242.